Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler
Bernstein, D.I., Berkowitz, R.B., Chervinsky, P., Dvorin, D.J., Finn, A.F., Gross, G.N., Karetzky, M., Kemp, J.P., Laforce, C., Lumry, W., Mendelson, L.M., Nelson, H., Pearlman, D., Rachelefsky, G., Ratner, P., Repsher, L., Segal, A.T., Selner, J.C., Settipane, G.A., Wanderer, A., Cuss, F.M., Nolop, K.B., Harrison, J.E.
Published in Respiratory medicine (01.09.1999)
Published in Respiratory medicine (01.09.1999)
Get full text
Journal Article
37 Asthma control improves while oral prednisone usage is reduced in patients with severe persistent asthma receiving inhaled mometasone furoate (MF) therapy
Fish, J.E, Craig, T.J, Bensch, G.W, Nolop, K.B, Harrison, J.E
Published in Journal of allergy and clinical immunology (2000)
Published in Journal of allergy and clinical immunology (2000)
Get full text
Journal Article